» Articles » PMID: 38612716

The Role of Inflammation in Lymphedema: A Narrative Review of Pathogenesis and Opportunities for Therapeutic Intervention

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Apr 13
PMID 38612716
Authors
Affiliations
Soon will be listed here.
Abstract

Lymphedema is a chronic and progressive disease of the lymphatic system characterized by inflammation, increased adipose deposition, and tissue fibrosis. Despite early hypotheses identifying lymphedema as a disease of mechanical lymphatic disruption alone, the progressive inflammatory nature underlying this condition is now well-established. In this review, we provide an overview of the various inflammatory mechanisms that characterize lymphedema development and progression. These mechanisms contribute to the acute and chronic phases of lymphedema, which manifest clinically as inflammation, fibrosis, and adiposity. Furthermore, we highlight the interplay between current therapeutic modalities and the underlying inflammatory microenvironment, as well as opportunities for future therapeutic development.

Citing Articles

Similarities and differences in the clinical features and management of primary lymphedema and kaposiform hemangioendothelioma associated with lymphedema in children.

Zhang Y, Qiu T, Yang C, Zhou J, Yang M, Gong X Front Pediatr. 2025; 13:1480213.

PMID: 40026487 PMC: 11869848. DOI: 10.3389/fped.2025.1480213.


Dynamics of Immune Cell Infiltration and Fibroblast-Derived IL-33/ST2 Axis Induction in a Mouse Model of Post-Surgical Lymphedema.

Uemura K, Katayama K, Nishioka T, Watanabe H, Yamada G, Inoue N Int J Mol Sci. 2025; 26(3).

PMID: 39941140 PMC: 11818732. DOI: 10.3390/ijms26031371.


SIX1 aggravates the progression of spinal cord injury in mice by promoting M1 polarization of microglia.

Xu Z, Zhu M, Xie H, Zhu J, Zheng H, Liu X Sci Rep. 2025; 15(1):1283.

PMID: 39779741 PMC: 11711668. DOI: 10.1038/s41598-024-82121-3.


The effect of compression therapies and therapeutic modalities on lymphedema secondary to cancer: a rapid review and evidence map.

McNeely M, Shallwani S, Al Onazi M, Lurie F Med Oncol. 2024; 41(11):288.

PMID: 39417951 PMC: 11486789. DOI: 10.1007/s12032-024-02447-w.


Incidence of lymphedema related to various cancers.

Letellier M, Ibrahim M, Towers A, Chaput G Med Oncol. 2024; 41(10):245.

PMID: 39289260 PMC: 11408551. DOI: 10.1007/s12032-024-02441-2.

References
1.
Randolph G, Ivanov S, Zinselmeyer B, Scallan J . The Lymphatic System: Integral Roles in Immunity. Annu Rev Immunol. 2016; 35:31-52. PMC: 5551392. DOI: 10.1146/annurev-immunol-041015-055354. View

2.
Sano M, Hirakawa S, Sasaki T, Inuzuka K, Katahashi K, Kayama T . Role of Subcutaneous Adipose Tissues in the Pathophysiology of Secondary Lymphedema. Lymphat Res Biol. 2022; 20(6):593-599. DOI: 10.1089/lrb.2021.0054. View

3.
Ridner S, Dietrich M, Deng J, Ettema S, Murphy B . Advanced pneumatic compression for treatment of lymphedema of the head and neck: a randomized wait-list controlled trial. Support Care Cancer. 2020; 29(2):795-803. PMC: 7767900. DOI: 10.1007/s00520-020-05540-8. View

4.
Shallwani S, Hodgson P, Towers A . Examining Obesity in Lymphedema: A Retrospective Study of 178 New Patients with Suspected Lymphedema at a Canadian Hospital-Based Clinic. Physiother Can. 2021; 72(1):18-25. PMC: 8330978. DOI: 10.3138/ptc-2018-0076. View

5.
Baik J, Park H, Kataru R, Savetsky I, Ly C, Shin J . TGF-β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation. Clin Transl Med. 2022; 12(6):e758. PMC: 9160979. DOI: 10.1002/ctm2.758. View